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Objectives. This study was designed to determine whether 
enhanced sensitivity to exogenous nitrovasodifators is present in 
the coronary arteries of patients with impaired endotbelium- 
dependent dilation. 
Background. Animal studies have demonstrated that the dila- 
tor response to exogenous nitrovasooiiators is exaggerated in the 
setting of endothelial dysfunction (diminished nitric ox& activ- 
ity). Whether suck relative byperresponsiveness to exogenous 
nitrates occurs and is important in humans is unknown. 
Methods. We assessed coronary vasomotion in 110 patients 
(mean [&SD] age 56 -t 10 years) by serial intracoronary infusions 
of acetylcholine (IQ-’ to tO-’ moQliter) to test endogenous nitric 
oxide and nitroglycerin (40 pg) to test responses to exogenous 
uitrovasodilators. 
Resuffs. The vasomotor response to 1tP6 mol/iiter of acetylcbo- 
line differed between patients with (n = 95) and those without 
(n = 15) normal endotheliai dysfunction (-214 14% vs. 12 f g%, 
The normal vascular endothelium maintains vasodilation 
through the release of paracrine factors such as nitric oxide (1). 
In response to a variety of pharmacologic stimuli, such as 
acetylcholine, or physiologic stimuli, such as shear stress, the 
endothelium releases nitric oxide, which binds to soluble 
guanylate cyclase, increasing the concentration of cyclic 
guanosine monophosphate (2). This is the same final common 
pathway used by nitrovasodilators to produce vasorelaxation 
(3). It has thus been postulated that important interactions 
might exist between endogenous nitric oxide and exogenous 
nitrovasodilators. 
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respectively, p < 0.001). However, neither the dilator response to 
nitroglycerin (21 + 14% vs. 18 2 13%) nor the baseline diameter 
differed between those with endothetial dysfunction and normal 
function, respectively. There was no correlation between the 
magnitude of the dilator response to nitroglycerin and acetylcho- 
lime. The response to nitroglycerin was decreased with increasing 
age (r = -0.21, p = 0.03) but was not related to any other 
demographic factors or to the angiographic appearance of the 
vessel. 
Conclusions. The coronary vasodilator response to nitroglyc- 
erin is not significantly enhanced in patients with impaired 
endothelium-dependent dilation but decreases with increasing 
age. This finding provides indirect evidence that basal coronary 
tone is not increased in patients with endotbelial dysfunction and 
that supersensitivity to exogenous nitrates is not clinically impor- 
tant in humans. 
(J Am Co11 Cardid 1996;28:5~0- 4) 
In response to risk factors or overt atherosclerosis in 
humans, abnormal endothelium-dependent vasomotor re- 
sponses have been observed as a result of a diminished nitric 
oxide effect (4,.5). However, in these and other studies the 
vasodilator response to exogenous nitrates has been main- 
tained (6,7), This finding has been interpreted as normal 
smooth muscle cell function, despite endothelial cell dysfmrc- 
tion. 
Many, but not all, animal studies have shown an increased 
sensitivity to nitroglycerin in the setting of endothelial dysfunc- 
tion, after removal of the endothelium or after blockade of 
nitric oxide (S-10). It has been suggcsled that this is similar to 
the supersensitivity seen after denervation, with upregulation 
of receptors. This may occur as a result of alterations in basal 
tone in the setting of endothelial dysfunction. Other suggested 
mechanisms include the loss of partial tolerance of endoge- 
nous nitric oxide on the effect of exogenously administered 
nitrates and a decrease in reactive oxygen species produced by 
the endothelium (11). 
Previous human studies have not determined whether such 
a supersensitivity to exogenous nitrates exists in human coro- 
nary arteries. The purpose of the present study was to compare 
the coronary vasodilator response to nitroglycerin in a large 
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cohort of patients with and without impaired endothelium- 
dependent vasomotor responses to acetylcholine. 
Methods 
P&ients. The study included 110 consecutive patients (72 
men, 38 women; mean [-tSD] age 56 Z!Z 10 years, range 34 to 
76) who underwent endorhelial function testing in the cardiac 
catheterization laboratory and also received intracoronary 
ntroglycerin. All studies were carried out in the morning. 
Significant coronary artery disease (at least’ one stenosis 
>50%) was present in 78 patients (71%); the remaining 32 
patients (29%) had normal coronary anatomy. Risk factors 
were present as follows: hypertension in 54 patients (49%), 
diabetes meilitus in 11 (IO%), cigarette smoking in 38 (35’S), 
family history in 47 (43%) and hypercholesterolemia in SS 
(53%). Mean total, low density lipoprotein and high density 
lipoprotein cholesterol levels for the group were 5.2 + 0.85, 
3.4 + 0.85 and 1.0 + 11.26 mmohliter, respectively, 
Study protocol: coronary endothelial function study. Long- 
acting vasoactive medications, including calcium clrannel 
blocking agents, beta-adrenergic blocking agents, nitrates and 
angiotensin-converting enzyme inhibitors, were discontinued 
for at least 18 h before catheterization. Written informed 
consent was obtained from all patients before the catheteriza- 
tion procedure in accordance with the guidelines established 
by the Committee for the Protection of Human Subjects. 
After a guiding catheter was positioned in the left main 
coronary artery and 10,000 IU of heparin was infused, a 2.5F 
infusion catheter was advanced through the guiding catheter 
over a 0.014-in. (0.035 mm) guide wire into the proximal 
portion of the left anterior descending or circumflex coronary 
artery. Serial intracoronary infusions were made according to an 
established protocol: 1) control infusion (5% dextrose in water): 
2) serial 2.5-min infusions of the endotheliumdependent vasodi- 
lator acetylcholine (Miochol, Ioiab Pharmaceuticals) in doses of 
0,16,1.6 and 16 pglmin, achieving a final estimated intracoronary 
concentration of 10-s, low7 and 10K6 moPliter, respectively: 3) 
5-min recontrol infusion of 5% dextrose in water; 4) 3-ruin 
infusion of the endothelium-independent vasodilator nitroglyc- 
erin at 16 pg/min (10m6 moh’hter) (4). During each infusion, 
blood pressure, heart rate and the electrocardiogram were con- 
tinuously monitored. 
Quantitative coronary angiographic images were taken af- 
ter each intervention (4,7). Nonionic contrast medium (Qm- 
nipaque, Winthrop Laboratories) was injected into the left 
main coronary artery at 7 ml/s for a total of 9 ml with a power 
injector (Medrad) to opacify the coronary artery. 
Qaantitative coronary angiography. An automated edge 
detection program was used to search densities and ?eek 
inflection points, thus measuring the segment diameter of the 
vessel along the length of the selected segment (ImageComm, 
Quantum IC software). Two segments 8 to IO mm in length 
were selected for analysis prospectively, on the basis of optimal 
regions for quantitative angiographic analysis. The vasomotor 
responses for the two segments in each patient were averaged 
to create a mean vdsodiiator response to acetylcholine and 
nitroglycerin. 
For the purpose of classifjiing the coronary vasomotor 
response dichotomously, patients in whom either of the two 
coronary segments r’::;stricted significantly (:>5% from base- 
line) were classified BS having coronary endothelial dysfunc- 
tion. All other patients were considered to have normal 
coronary endothelial function. 
The coronary an.giograms were reviewed by an observer 
(I.T.M.) who had no knowledge of the results of the vasodila- 
tor function studies and were coded as to the number of major 
epicardial vessels stenosed (>50%) and whether or not they 
were smooth or irregular. only pa Gents in whom the epicardial 
coronary arteries were completely smooth were classified as 
having no angiographic coronary disease. 
Statistisal analysis. The digerences in demographics and 
acetylcholine and nitroglycerin responses between patients 
with endothehal dysfunction and normal function were com- 
pared by unpaired t tests. The continuous relation between 
patient demographics or vasomotor response to acetylcholine 
and that for the dilator response to nitroglycerin were com- 
pared with linear regression analysis. Statistical significance 
was defined as a two-tailed p value ~0.05. Results are ex- 
pressed as mean value t SD. The study had a 78% power to 
detect a clinically significant absolute difference of 10% in the 
coronary response to nitroglycerin. 
Resdts 
Coronary artery endothelial function. The study patients 
were classified as those with endothelial dysfunction {vasocon- 
striction >5% to acetylcholine, n = 95) and thcsd with normal 
endothelial function (vasodilator or no change in diameter to 
acetytcholine, n = 15) The patient demographics for the two 
groups are shown in Table 1, There was no significant differ- 
ence between the two groups with respect to risk fdctors, serum 
lipids or extent of coronary artery disease. Patients with 
endothelial dysfunction demonstrated constriction of 21 t 
14%, whereas patients with normal function showed vasodila- 
tion of I2 t 8% in response to acetylcholine. Tnere was no 
difference in baseline coronary diameter between the two 
groups (1.91 t 0.49 vs 1.89 -+ 0.36 mm, respectively). 
Vasodilator responses to nitrogIyserin. The coronary dila- 
tor response to nitroglycerin was not significantly different 
(21 f ‘14% vs. 18 1 13%) ktween patients with endothelial 
dysfunction and normal endothelial funaion, respectively (Fig- 
1). By regression analysis there was no relation between the 
vasomotor response to acetylcholine and nitroglycerin (r = 
0.06) (Fig. 2). There was also no relation between the degree 
of dilation to nitroglycerin and the baseline coronary diameter 
(r = 0.16). Neither the burden of atherosclerosis nor the 
presence of irregularities in the study vessel had any impact on 
the nitroglycerin response. The only patient demographic that 
correlated to dilator response was age (p = 0.029). Older 
patients tended to have less dilation in response to nrtroglyc- 
erin (Pig. 3). 
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Table 1. Patient Demographics .~~--~- 
Endothelial Normal Endothetial 
Dysfuoction (n = 95) Fl,irction (n = 15) 
--- -- 
A@ (yr) 56 14 10 5’): I2 
Cholesterol (mmolilitcr) 5.2 1- 0.8 5.2 k 0.7 
LDL cholesterol (mmok’liter) 3.4 i- w! 3.4 _f 0.8 
HDL cholesterol (mmol!liter) 1 .o 2 (f.2 I.0 t- to,: 
Triglycsridcs (mmoliliter) I.9 i 1.u 2.2 2 2.0 
Hypcrtcnsion 45% 739;> 
Diabetes mellitus 10% 134 
Cigarette use 14% 40% 
No, of risk factors 1.3 It 0.9 1.7 + 1.1 
Coronary disease 14% 47% 
__-“-- 
Data presented are mean value k SD or percent of patients. f IDL = high 
density lipoprotein cholesterol: LDL = low density lipoprolein ch&sterol. 
Because it is appreciated that the vasomotor responses 
along the length of the artery arc heterogeneous, acd averag- 
ing two segments/patient might mask a potential correlation, 
we also examined the relation between acetylcholine and 
nitroglycerin responses on a per-segment basis. A tota! of 220 
segments (1 proiimal and 1 distal/patient) were analyzed. The 
163 segments with an abnormal response to acetylchohne had 
a mean dilation in response to nitroglycerin of 21.6 + 16%, 
whereas the 57 normal segments dilated 16.7 k 15%. This 
difference was not significant when the data were corrected for 
multiple measurements in the same subject. 
Discussion 
The coronary vasodilator response to nitroglycerin is not 
significantly enha;lced in patients with impaired endothelium- 
dependent dilation despite similar baseline diameters, but does 
decrease with increasing age. This finding is in contradistinc- 
tion to many animal studies that have suggested a supersensi- 
tivity to nitrovasodilators in situations where endothelium- 
dependent nitric oxide activity is reduced. 
Interaction of nitric oxide and exogenous nitrates. In 
response to acetylcholine, the healthy endothelium releases 
Figure 1. Vasomotor esponses to acetylcholine and nitroglycerin for 
patients with and without endothelial dysfunction, No significant 
difference in dilator response to nitroglycerin was seen. Results shown 
are mean value t SE. 
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Figure 2. Continuous relation bclwecn dilator response to nitroglyc- 
erin (NTG, y axis) and acetylcholine (Ach, x asis). No correlation was 
found. Dia = diameter. 
nitric oxide, which modulates many biologic processes, includ- 
ing vasodiiation (12,i3). Nitric oxide acts through the cyclic 
guanosine monophosphate second-messenger system, the 
same final common pathway as exogenous nitrovasodilators. 
Thiol groups play a role in the biotransformation of nitrova- 
sodilators and may be important in the nitric oxide-heme 
interaction of soluble guanylate cyclase (14,lS). There is thus a 
potential for interaction between nitric oxide and the effects of 
exogenously administered nitrates. 
Moncada et al. (9) have demonstrated both in vitro and in 
vivo that there is an enhanced diiator response to nitroglycerin 
when nitric oxide is blocked or the endothelium is removed. 
This response appeared to occur at the kvel of soluble 
guanylate cyclase and may be analagous to the dennrvation 
supersensitivity that has been observed for ,100 years. An 
enhanced sensitivity to nitrovasodilators in the setting of 
endothelial dysfunction has also been demonstrated by other 
investigators ix a variety of animal models (8,16,17). However, 
this fi.lding has not been consistent, with some models of 
atherosclerosis demonstrating endothelial dysfunction with no 
enhancement of nitroglycerin response (18). The reason for 
the inconsistency is not clear but may relate to the cellular 
characteristics of the intimal lesions created in different animal 
models. A recently published study (19) demonstrated a gen- 
eralized enhancement of both a constrictor response to acetyl- 
choline (endotheiial dysfunction) as well as an enhanced 
dilator response to nitroglycerin in patients with vasospastic 
Figure 3. Relation between dilator response to nitroglycerin (NTG, y 
axis) and age. A modest inverse correlation was seen (p = 0.029). 
Dia = diameter. 
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angina. However, the study did not demonsnat,: an enhanced 
nitroglycerin response in patients without coronaryvasospasm. 
Rest vascular tone may hc increased with endothelial 
dysfunction because nitric oxide has been shown to be basally 
released (5,13). A recent study (5) demonstrated that in the 
presence of risk factors that are known to impair endothelium- 
dependent vasodilation, basal release of nitric oxide is im- 
paired compared with that in patients without risk factors. If 
the vr;sscl starts with relative vasoconstriction, then nitrovaso- 
dilators may cause r&t?: ely greater vasodilation when the 
endothchum is dysfunctional. This would be analogous to the 
postulate that the reduced basal formation of endothelium- 
derived nitric oxide in veins compared with that in arteries may 
explain why veins are nmre sensitive to the effects of nitrova- 
sodilators (20). 
Another possible mechanism of enhanced sensitivity to 
nitrovasodifators includes the withdrawal of partial tolerance 
induced by nitric oxide in a healthy vessel. This withdratval 
might occur as 2 result of alteration:; in the interaction betveen 
reactive thiol species, guanylate qclase and nitric oxide. 
Current study. Human st.udies hdve not specifically as- 
sessed the relation between responses to nitroglycerin and 
acetylcholine in large numbers of patients. Previous studies 
have demonstrated retained coronary dilator response to ni- 
trates in the setting of atherosclerosis and endothelial dysfunc- 
tion (4-7). In fact, some peripheral studies have shown a 
decrease in dilation in response to nitroprusside in patients 
with hypercholesterolemia or atherosclerosis compared with 
that in control subjects (21,22). 
In the present study we examined this relation in 110 
consecutive patients who underwent endothelial function test- 
ing with acetylcholine and intracoronary nitroglycerin. No 
correlation between the vasomotor response to acetylcholine 
and nitroglycerin was present. The vasodilator response to 
nitroglycerin was not enhanced in patients with endotheliai 
dysfunction. Although bass! tone is difficult to assess in viva, 
the baseline diameter of the coronary arteries was not different 
between the two groups, indirectly suggesting that tone was not 
different. 
It is unclear why in vitro studies have demonstrated a 
supersensitivity to nitrates whereas we were unable to show 
this response in human coronary arteries. It may be that the 
cndothelium needs to be physically removed or the level of 
nitric oxide activity more completely suppressed before this 
effect is seen. Quyyumi et al. (5) demonstrated in human 
coronary arteries that nitric oxide activity is decreased in 
patients with coronary risk factors but that some activity is still 
present. Also, only one dose of nitroglycerin was given, and it 
may be that if dose-response curves were obtained, a ditfer- 
ence in effect might be evident at, lower concentrations of 
nitroglycerin. There is also a ditference in the cellular charac- 
teristics of arteries from cholesterol-fed animals and athero- 
sclerotic humans, who may have advanced fibrocalcific changes 
that could potentially impair an enhanced nitroglycerin effect. 
The dilator response to nitroglycerin decreased with in- 
creasing age but was not dependent on coronary risk factors or 
the burden of atherosclerosis by angiography. This finding 
might represent a decreased sensitivity of the aging vascular 
smooth muscle ceil or simply a physical abnormality in the 
aging vessel. Older patients tend to have more calcification in 
their coronary arteries, which may physicall:j prevent dilation. 
Endothelium-dependent dilation of coronary resistance vessels 
decreases with advancing age independent of increasing bur- 
dens of atherosclerosis (23,24). The dihator response to the 
smooth muscle dilator papaverine was also shown to decrease 
with increasing age in a group of patients with normal coronary 
arteries (22). Thttf, aging most likely has an indepen- 
dent detrimental etfect on endothelium-dependent and 
endothelium-independent vasodilation in the coronary circu- 
!ation. 
Study limitations. Only one dose of nitroglycerin (40 pg 
over 2.5 min) was given to each patient. A dose-response curve 
ccmparison between patients with and without endothelial 
dysfunction may have been instructive. Perhaps there would 
hale been a difference in dilation at lower than maximal doses. 
Significant dilation probably does not occur above the dose 
used in this study (25), suggesting that the peak dilation to 
nitroglycerin is not enhanced in patients with endotheiiai 
dysfunction. 
The majority of the patients in the study had endothelial 
dysfunction, given the referral pattern to the catheterization 
laboratory. However, the baseline demogranhics were matched 
between the two groups. Larger numbers or’ patients may have 
allowed detection of a statistically significant but clinically 
unimportant difference of a few percentage points between the 
two groups. 
No longitudinal data are present in patients to coo5rm that 
aging impairs vascular sensitivity to nitrovasodilators. 
Cm~lusions. This study demonstrated that the coronary 
vasoditator response to nitroglycerin is not significantly en- 
hanced in patients with impaired endothelium-dependent di- 
lation but decreases with increasing age. This fmding provides 
indirect evidence that basal coronary tone is not inc;adsed in 
patients with endothelial dysfunction and that supersensitivity 
to exogenous nitrates is not clinically important in humans. 
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